<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sanchez-Conde FG</submitter><funding>American Heart Association</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>NIGMS NIH HHS</funding><pagination>890368</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9113952</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15</volume><pubmed_abstract>The ERG1 potassium channel, encoded by &lt;i>KCNH2&lt;/i>, has long been associated with cardiac electrical excitability. Yet, a growing body of work suggests that ERG1 mediates physiology throughout the human body, including the brain. ERG1 is a regulator of neuronal excitability, ERG1 variants are associated with neuronal diseases (e.g., epilepsy and schizophrenia), and ERG1 serves as a potential therapeutic target for neuronal pathophysiology. This review summarizes the current state-of-the-field regarding the ERG1 channel structure and function, ERG1's relationship to the mammalian brain and highlights key questions that have yet to be answered.</pubmed_abstract><journal>Frontiers in molecular neuroscience</journal><pubmed_title>The ERG1 K&lt;sup>+&lt;/sup> Channel and Its Role in Neuronal Health and Disease.</pubmed_title><pmcid>PMC9113952</pmcid><funding_grant_id>T32 GM140223</funding_grant_id><pubmed_authors>Jones DK</pubmed_authors><pubmed_authors>Jimenez-Vazquez EN</pubmed_authors><pubmed_authors>Auerbach DS</pubmed_authors><pubmed_authors>Sanchez-Conde FG</pubmed_authors></additional><is_claimable>false</is_claimable><name>The ERG1 K&lt;sup>+&lt;/sup> Channel and Its Role in Neuronal Health and Disease.</name><description>The ERG1 potassium channel, encoded by &lt;i>KCNH2&lt;/i>, has long been associated with cardiac electrical excitability. Yet, a growing body of work suggests that ERG1 mediates physiology throughout the human body, including the brain. ERG1 is a regulator of neuronal excitability, ERG1 variants are associated with neuronal diseases (e.g., epilepsy and schizophrenia), and ERG1 serves as a potential therapeutic target for neuronal pathophysiology. This review summarizes the current state-of-the-field regarding the ERG1 channel structure and function, ERG1's relationship to the mammalian brain and highlights key questions that have yet to be answered.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-20T03:05:03.979Z</modification><creation>2024-12-04T00:35:22.183Z</creation></dates><accession>S-EPMC9113952</accession><cross_references><pubmed>35600076</pubmed><doi>10.3389/fnmol.2022.890368</doi></cross_references></HashMap>